Journal
CLINICAL MICROBIOLOGY AND INFECTION
Volume 18, Issue 7, Pages E246-E247Publisher
ELSEVIER SCI LTD
DOI: 10.1111/j.1469-0691.2012.03880.x
Keywords
antifungals; Candida; Cryptococcus; EUCAST; minimum inhibitory concentration; susceptibility testing; yeast
Categories
Funding
- National Institute of Health (NIHR)
- Astellas
- Gilead
- MSD
- Pfizer
- Astellas Pharma
- bioMerieux
- Gilead Sciences
- Schering Plough
- Soria Melguizo SA
- European Union
- ALBAN
- Spanish Agency for International Cooperation
- Spanish Ministry of Culture and Education
- Spanish Health Research Fund
- Instituto de Salud Carlos III
- Ramon Areces Foundation
- Mutua Madrilena Foundation
- Merck
- Vectura
- F2G
Ask authors/readers for more resources
Clin Microbiol Infect 2012; 18: E246E247 Abstract The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has revised the EDef 7.1 document on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for fermentative yeasts. Changes are: dimethylsulphoxide is now the recommended solvent for caspofungin, micafungin and fluconazole; the shelf-life of plates containing the echinocandins prepared from stock solutions in dimethylsulphoxide is extended to 6 months at -80 degrees C; testing of amphotericin and Cryptococcus has been incorporated; and minimum inhibitory concentration ranges for quality control strains and anidulafungin are included.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
